Key result
Tapered LVOT morphology linked to ~147% greater risk of device migration and embolization during TAVI.
Why the study?
The effect of a tapered LVOT on periprocedural outcomes in native severe aortic stenosis treated with self-expandable valves remained unclear.
Does tapered LVOT morphology increase the risk of incomplete periprocedural device migration in patients with severe native AVS undergoing TAVI with a self-expandable intraannular prosthesis?
Cohort (n=354)
Does tapered LVOT morphology increase the risk of incomplete periprocedural device migration in patients with severe native AVS undergoing TAVI with a self-expandable intraannular prosthesis?
Odds Ratio: 2.47 (95% CI 1.26–4.87)
Absolute Event Rate: 18.9% vs 6.6%
p-value: p=0.009
Tapered LVOT morphology is associated with a significantly increased risk of incomplete periprocedural device migration during TAVI with self-expandable intraannular prostheses, highlighting the need for careful preprocedural anatomical assessment.
Tapered LVOT may raise PPI risk after SE-TAVI for native AS; leaves open whether morphology should guide valve selection or depth.
BACKGROUND: A tapered left ventricular outflow tract (LVOT) may influence outcomes in transcatheter aortic valve implantation (TAVI), especially regarding valve positioning and conduction disturbances. While this is established in cases of pure aortic regurgitation and stenosis with balloon-expandable valves, its effect in native high-grade aortic stenosis (AVS) using self-expandable (SE) valves remains unclear. This study evaluated the impact of tapered LVOT morphology on peri-procedural outcomes with a SE intraannular (IA) TAVI prosthesis. METHODS: Between June 2021 and April 2025, 354 patients with severe native AVS underwent TAVI using the SE IA TAVI prosthesis. Patients were stratified based on LVOT morphology (tapered vs. non-tapered). Clinical and hemodynamic outcomes, including incomplete periprocedural device migration (IPDM) and embolization, were compared between groups. RESULTS: Technical success (96.9% tapered vs. 97.8% non-tapered, p = 0.727) and device success (92.9% vs. 89.4%, p = 0.373) were similarly high. IPDM occurred significantly more often in patients with a tapered LVOT (18.9% vs. 6.6%, p = 0.001). Overall, rates of embolization (0.8% vs. 2.6%, p = 0.429) and Valve-in-Valve procedures (0.8% vs. 1.8%, p = 0.658) were rare. Multivariate logistic regression identified a tapered LVOT morphology (OR 2.47; 95% CI 1.26-4.87; p = 0.009) and severe aortic valve eccentricity (OR 2.16; 95% CI 1.03-4.57; p = 0.042) as independent predictors for IPDM and embolization. The rate of permanent pacemaker implantation was comparable (17.4% vs. 18.0%; p = 1.000). CONCLUSION: TAVI with the SE IA prosthesis demonstrated high procedural success across anatomical subgroups. However, a tapered LVOT was associated with a significantly increased risk of incomplete periprocedural device migration. In such cases, a slightly deeper implantation may enhance anchoring and stability. These findings highlight the critical importance of preprocedural anatomical assessment, particularly LVOT morphology, in optimizing outcomes for TAVI in native AVS.
No takes yet. Share an insight, caveat, or question.
Eckel et al. (2026) conducted a cohort in Severe native aortic valve stenosis (n=354). Tapered LVOT morphology vs. Non-tapered LVOT morphology was evaluated on Incomplete periprocedural device migration (IPDM) and embolization (OR 2.47, 95% CI 1.26-4.87, p=0.009). Tapered LVOT morphology was associated with a significantly increased risk of incomplete periprocedural device migration and embolization during TAVI (OR 2.47; 95% CI 1.26-4.87; p=0.009).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: